Crossmark

Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer’s disease preclinical phase evaluated by dual-phase 18F-florbetaben positron emission tomography

Crossref DOI link: https://doi.org/10.1038/s41598-024-68916-4

Published Online: 2024-08-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Geon Ha

Kim, Bori R.

Yoon, Hai-Jeon

Jeong, Jee Hyang
Funding

Funding for this research was provided by:

Korea Health Industry Development Institute (HU20C0271)

National Research Foundation of Korea,South Korea (NRF-2021R1A2C1093636)
License Information

Text and Data Mining valid from 2024-08-09

Version of Record valid from 2024-08-09
More Information

Article History

Received: 11 March 2024

Accepted: 30 July 2024

First Online: 9 August 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below